Home > Stocks > Highlights
Dow 30 Earnings: Chevron Corp. Second Quarter 2015
Chevron, the world's fourth-largest oil company based on proven reserves, saw its second-quarter sales and earnings fall sharply from a year earlier, as declines in oil and natural gas prices took a toll, as did costs associated with decommissioning rigs and facilities. Read more
Dow 30 Earnings: Exxon Mobil Corp. Second Quarter 2015
Oil giant Exxon Mobil has reported second-quarter share earnings of $1.00, close to our estimate, but significantly below the year-earlier tally. The steep decline in oil prices over the past year proved a major stumbling block for corporate results, as did lower natural gas price realizations. Read more
Dow 30 Earnings: Procter and Gamble Fourth Quarter Fiscal 2015
Household goods conglomerate and Dow-30 component Procter and Gamble  has announced fourth-quarter and fiscal 2015 results (year ended June 30th). The company posted top- and bottom-line declines for the full year, mainly due to currency headwinds. In response, the stock's price slipped. Read more
Using the Value Line Report: 3M Company Consistently Manufacturing Better Results
3M Company (MMM) is a diversified manufacturer and technology company with operations in more than 70 countries. The Dow-30 component has a bevy of divisions with substantial positions in everything from the industrial realm to the consumer world. It set records last year in terms of both revenue and earnings with totals of $31 billion and $7.49 a share, respectively. The stock recently traded at a new all-time high at just north of $170 a share. With that, we will take a look at the July 17, 2015 Value Line report to get a better idea of which type of investors these shares are best suited for at this juncture. Read more
Dow 30 Earnings: Merck Second Quarter 2015
Merck a New Jersey-based drugmaker and Dow-30 component, has reported second-quarter adjusted earnings of $0.86 a share, versus $0.85 in the comparable period of 2014. The bottom-line tally came in ahead of our $0.80 estimate thanks to better-than-expected sales growth in diabetes and cancer drugs, partially offset by a negative impact from the stronger dollar. Read more
Dow 30 Earnings: Pfizer Second Quarter 2015
Strong gains in the PREVNAR vaccine franchise and better sales of the new breast cancer drug IBRANCE helped Pfizer’s (PFE) second-quarter results to top expectations. Read more
Dow 30 Earnings: DuPont Second Quarter 2015
Diversified chemicals manufacturer and Dow-30 component DuPont delivered weaker-than-expected second-quarter results. Although operating margins improved in five of the company's six operating segments, driven by increased productivity, a stronger U.S. dollar hurt performance across the board. Read more
Dow 30 Earnings: Visa Inc. Fiscal Third Quarter 2015
Electronic payments processor Visa (V) has reported stellar results for the fiscal 2015 third quarter, and shares of the Dow-30 component moved notably higher in pre-market trading, as a result. Read more
Dow 30 Earnings: 3M Company Second Quarter 2015
Diversified manufacturer and Dow-30 component 3M Company (MMM) posted disappointing second-quarter results, sending its stock down. Read more
Dow 30 Earnings: Caterpillar Inc. Second Quarter 2015
 Caterpillar (CAT) shares were a bit lower in early trading, touching a new 52-week low, after the heavy equipment manufacturer and Dow-30 staple lowered guidance for this year. Read more
[First] [Previous] [Next] [last]
Free stock reports
The Value Line 600
Value Line is regarded as the best independent research available. More than just recommendations, Value Line provides the rationale behind its picks for greater understanding.
- Don D., California